生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Masitinib is an inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, weak inhibition to ABL and c-Fms. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00831922 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00831974 | Mastocytosis | Phase 2 | Completed | - | - |
NCT01045577 | Psoriasis | Phase 2 | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.01mL 0.40mL 0.20mL |
10.03mL 2.01mL 1.00mL |
20.05mL 4.01mL 2.01mL |
参考文献 |
---|